Studies demonstrated that CEACAM6 is overexpressed in several human malignancies, including colorectal adenomas and carcinomas, gastric carcinomas, and pancreatic carcinomas etc.[17, 27–29]. This evidence concerns the gene CEACAM6 and exocrine pancreatic carcinoma.